4//SEC Filing
Gamelin Erick 4
Accession 0000905148-25-000836
CIK 0001781174other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:24 PM ET
Size
5.2 KB
Accession
0000905148-25-000836
Insider Transaction Report
Form 4
Gamelin Erick
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-01+78,078→ 78,078 totalExercise: $5.31Exp: 2035-02-28→ Common Stock (78,078 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0001950551
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:24 PM ET
- Size
- 5.2 KB